Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic stem cell aging: mechanism and consequence.

Derrick J Rossi1, David Bryder, Irving L Weissman

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA. drossi@stanford.edu

Experimental Gerontology
|February 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate.

Blood·2026
Same author

Improving lymphopoiesis in aged bone marrow.

Current opinion in hematology·2026
Same author

Ontogeny-specific induction of the KMT2A::AFF1-fusion drives development of a distinct CD24 positive pre-leukemic state.

Leukemia·2025
Same author

PUS10-induced tRNA fragmentation impacts retrotransposon-driven inflammation.

Cell reports·2025
Same author

Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration.

Cell reports·2024
Same author

Revitalizing the Aging Immune System Through Selective Stem Cell Targeting.

Cellular reprogramming·2024
Same journal

Ayurvedic nutraceutical, Chyawanprash, enhances longevity and stress resilience via mitochondrial and muscular health in C. elegans model of ageing.

Experimental gerontology·2026
Same journal

Activation of Sirt3 reprograms mitochondrial function to regenerate intervertebral disc degeneration.

Experimental gerontology·2026
Same journal

Sit-to-stand power shows greater magnitude associations with radial bone strength compared to handgrip strength in adults aged 60-95 years: A cross-sectional study.

Experimental gerontology·2026
Same journal

Impact of simultaneous motor-cognitive training on motor capacities in older adults: A quasi-randomized parallel controlled trial.

Experimental gerontology·2026
Same journal

Triglyceride-glucose-related metabolic indices, phenotypic aging, and incident pulmonary embolism.

Experimental gerontology·2026
Same journal

A comparative study reveals distinct patterns of resting-state activity in tinnitus and chronic pain.

Experimental gerontology·2026
See all related articles

Aging impairs blood cell production due to changes in hematopoietic stem cells. These stem cell functional declines contribute to immune system weakening and increased myeloproliferative diseases in older adults.

Area of Science:

  • Hematology
  • Immunology
  • Gerontology
  • Stem Cell Biology

Background:

  • Advancing age is associated with various hematological conditions.
  • Diminished homeostatic control of blood cell production is a hallmark of aging.
  • Hematopoietic stem and progenitor cells regulate blood cell production and are implicated in age-related diseases.

Purpose of the Study:

  • To investigate the role of hematopoietic stem cells (HSCs) in age-associated hematological conditions.
  • To explore the cell-autonomous changes in HSCs contributing to immune senescence and myeloproliferative diseases.

Main Methods:

  • Analysis of HSC function in aging models.
  • Investigating molecular mechanisms underlying HSC aging.

Related Experiment Videos

  • Correlating HSC functional decline with clinical manifestations of aging.

    • Main Results:

    • Evidence suggests age-related functional decline in HSCs.
    • These HSC changes are linked to immune system diminution.
    • HSC functional alterations are also associated with increased incidence of myeloproliferative diseases.

    Conclusions:

    • Cell-autonomous changes in HSCs are a key factor in age-associated hematological disorders.
    • Targeting HSC aging may offer therapeutic strategies for age-related immune dysfunction and myeloid malignancies.